News

AddToAny

Google+ Facebook Twitter Twitter

Diagnose bacterial infections in less than an hour

Engineers, biochemists and medical researchers have combined their skills to create a rapid test for bacterial infections.

They say the handheld device can produce accurate, reliable results in less than an hour.

Their proof-of-concept research has been published in the journal Nature Chemistry and specifically describes the test’s effectiveness in diagnosing urinary tract infections from real clinical samples.

The researchers are adapting the test to detect other forms of bacteria and for the rapid diagnosis of viruses, including SARS-CoV-2. They also plan to test its viability for detecting markers of cancer.

Leyla Soleymani, one of the authors of the paper, said: “It’s going to mean that patients can get better treatment, faster results and avoid serious complications. It can also avoid the unnecessary use of antibiotics, which is something that can buy us time in the battle against antimicrobial resistance.”

The new DNA-based technology uses a device similar to a blood-glucose monitor. A microchip analyses a droplet of bodily fluid using molecules that can detect the specific protein signature of an infection. The device, about the size of a USB stick, plugs into a smartphone, which displays the results.

go.nature.com/2Uc9KNz

Image Credit | JD Howell McMaster University

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top